Trial Profile
Electronic study for anastrozole pharmacovigilance evaluation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Aug 2008
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary)
- Indications Early breast cancer
- Focus Adverse reactions
- Sponsors AstraZeneca
- 25 Jul 2008 The actual completion date has been identified as Jul 2008, as reported by ClinicalTrials.gov.
- 23 Nov 2007 New trial record.